Search Results 251-260 of 9780 for Nuedexta

  1. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  2. Fatty Liver Disease (MASLD) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare the incidence and frequency of elevated liver enzymes or parenteral (IV) nutrition-associated liver disease, in adult ...

  3. Hematology - Clinical trials

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  4. Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases - Mayo Clinic

    About this study. The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the ...

  5. Hematology - Clinical trials

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  6. Multiple endocrine neoplasia, type 1 (MEN 1) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  7. PREemptive Pharmacogenomic testing for prevention of Adverse drug REactions - Mayo Clinic

    About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...

  8. How Lutathera attacks neuroendocrine tumors - Mayo Clinic

    Lutathera, the first FDA -approved peptide receptor radionuclide therapy, or PRRT , allows for precision targeting of NETs cells. Lutathera consists mainly of ...

  9. Neurology - Clinical trials - Mayo Clinic

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  10. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...